Lykos Therapeutics Releases Statement on FDA Advisory Committee Meeting
Following the vote of the US Food and Drug Administration Psychopharmacologic Drugs Advisory Committee, Lykos has released a statement on MDMA-assisted therapy.
Stay updated with breaking news from Protocol Assessment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following the vote of the US Food and Drug Administration Psychopharmacologic Drugs Advisory Committee, Lykos has released a statement on MDMA-assisted therapy.
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
Commencement of ONS-5010 NORSE EIGHT clinical trial targeted for first calendar quarter of 2024Company reaffirms potential for European approval for...
Commencement of ONS-5010 NORSE EIGHT clinical trial targeted for first calendar quarter of 2024Company reaffirms potential for European approval for ONS-5010 with Marketing Authorization Application ...
The Government of Canada takes any attempt at foreign interference, including in Canada's democratic institutions and processes, very seriously. That's why the government continues to improve, strengthen, and protect our democracy from these threats....